PeerView Family Medicine & General Practice CME/CNE/CPE Audio Podcast

Podcast készítő PVI, PeerView Institute for Medical Education

290 Epizód

Nancy S. Reau, MD - Plugging the Gaps in Hepatitis B and C Care: Understanding and Integrating New Guidelines and Advances in Disease Management
Közzétéve: 2024. 12. 27.
Ira M. Jacobson, MD - In Pursuit of a Functional Cure for Hepatitis B: Monitoring Effectively, Optimizing Treatment, and Reducing Risk of Complications
Közzétéve: 2024. 12. 12.
Jason J. Luke, MD, FACP - Resect and Protect Against Melanoma Recurrence: Are You Prepared for the Present and Future of Adjuvant Immunotherapy for Stage II-III Disease?
Közzétéve: 2024. 11. 29.
Chris A. Liacouras, MD - Optimizing Outcomes for Pediatric Patients With EoE: The Importance of Timely Integration of Targeted Biologic Treatment
Közzétéve: 2024. 11. 29.
Kevin Ault, MD, FIDSA, FACOG - The Burden of RSV in Pediatric Populations: Evidence for Reshaping Care and Optimizing Prophylaxis
Közzétéve: 2024. 11. 22.
Mirna Chehade, MD, MPH, AGAF, FAAAAI / Evan S. Dellon, MD, MPH - Early Diagnosis and Evolving Management of Eosinophilic Esophagitis in the Era of Targeted Therapy
Közzétéve: 2024. 11. 22.
Fuad El Rassi, MD, Modupe Idowu, MD - A New Script for SCD Care: Guidance on Patient-Centric Treatment Decisions With Innovative Therapeutics
Közzétéve: 2024. 11. 21.
Guillermo E. Umpierrez, MD, CDE, FACP, FACE - Prioritizing Weight Management as a Primary Goal in People With Type 2 Diabetes: An Office Hours Activity
Közzétéve: 2024. 11. 11.
James F. Howard Jr., MD, FAAN / Nicholas J. Silvestri, MD, FAAN - Steering Away From Steroids in Myasthenia Gravis Management: The Role of FcRn Inhibitors in the Current Treatment Paradigm
Közzétéve: 2024. 11. 11.
Irl Hirsch, MD, MACP - The New Normal: Digital Technologies for People Living With Insulin-Treated Type 2 Diabetes
Közzétéve: 2024. 11. 11.
Patrick M. Moriarty, MD, FACP, FACC, FNLA, FESC - Changing the Future for Families With HoFH: Long-Term Benefits of Early Diagnosis and Treatment for Homozygous Familial Hypercholesterolemia
Közzétéve: 2024. 11. 01.
Pamela J. McShane, MD - Experts vs AI Challenge: Diagnosing and Managing Nontuberculous Mycobacterial Lung Disease
Közzétéve: 2024. 11. 01.
April W. Armstrong, MD, MPH - Staying on Target Against Moderate to Severe Psoriasis: Strategies for Achieving Sustained Benefits Through TYK2 Inhibition
Közzétéve: 2024. 10. 28.
Gil Rabinovici, MD - At the Ready for a New Standard of Alzheimer's Care: Preparing Your Practice for the New Era of Amyloid-Targeting Therapies
Közzétéve: 2024. 10. 22.
Onyema Ogbuagu, MD, FACP, FIDSA - Adjusting HIV Treatment for ART-Experienced People With HIV: Switching ART to Address Antiretroviral Resistance, Adverse Events, and Adherence Barriers
Közzétéve: 2024. 10. 02.
Komal Jhaveri, MD, FACP - Embracing Progress, Transforming Treatment, Empowering Patients: Harnessing the Potential of TROP2-Targeted ADC Therapy in TNBC and HR+, HER2- Breast Cancer
Közzétéve: 2024. 10. 02.
Marc S. Sabatine, MD, MPH - Emerging Options for Targeting PCSK9 in Hypercholesterolemia Management: Visualizing New Routes to Individualized Care
Közzétéve: 2024. 09. 23.
Jacinda (JAM) Abdul-Mutakabbir, PharmD, MPH - Pharmacist-Led RSV Immunization Strategies: Leveraging Trust to Overcome Vaccine Hesitancy
Közzétéve: 2024. 09. 06.
April W. Armstrong, MD, MPH - All Things Considered in Psoriasis Management: Looking at the Role of Biologic Therapies in a Holistic Approach
Közzétéve: 2024. 09. 06.
Bradley J. Monk, MD, FACS, FACOG - Advancing Immunotherapy: Revolutionizing Cervical Cancer Treatment
Közzétéve: 2024. 08. 28.

2 / 15

PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support specific specialties and conditions. Each episode includes a link to request CME/CE credit for participation. PeerView is solely responsible for the selection of topics, the preparation of editorial content, and the distribution of all materials it publishes.

Visit the podcast's native language site

290 Epizód

Nancy S. Reau, MD - Plugging the Gaps in Hepatitis B and C Care: Understanding and Integrating New Guidelines and Advances in Disease Management

Ira M. Jacobson, MD - In Pursuit of a Functional Cure for Hepatitis B: Monitoring Effectively, Optimizing Treatment, and Reducing Risk of Complications

Jason J. Luke, MD, FACP - Resect and Protect Against Melanoma Recurrence: Are You Prepared for the Present and Future of Adjuvant Immunotherapy for Stage II-III Disease?

Chris A. Liacouras, MD - Optimizing Outcomes for Pediatric Patients With EoE: The Importance of Timely Integration of Targeted Biologic Treatment

Kevin Ault, MD, FIDSA, FACOG - The Burden of RSV in Pediatric Populations: Evidence for Reshaping Care and Optimizing Prophylaxis

Mirna Chehade, MD, MPH, AGAF, FAAAAI / Evan S. Dellon, MD, MPH - Early Diagnosis and Evolving Management of Eosinophilic Esophagitis in the Era of Targeted Therapy

Fuad El Rassi, MD, Modupe Idowu, MD - A New Script for SCD Care: Guidance on Patient-Centric Treatment Decisions With Innovative Therapeutics

Guillermo E. Umpierrez, MD, CDE, FACP, FACE - Prioritizing Weight Management as a Primary Goal in People With Type 2 Diabetes: An Office Hours Activity

James F. Howard Jr., MD, FAAN / Nicholas J. Silvestri, MD, FAAN - Steering Away From Steroids in Myasthenia Gravis Management: The Role of FcRn Inhibitors in the Current Treatment Paradigm

Irl Hirsch, MD, MACP - The New Normal: Digital Technologies for People Living With Insulin-Treated Type 2 Diabetes

Patrick M. Moriarty, MD, FACP, FACC, FNLA, FESC - Changing the Future for Families With HoFH: Long-Term Benefits of Early Diagnosis and Treatment for Homozygous Familial Hypercholesterolemia

Pamela J. McShane, MD - Experts vs AI Challenge: Diagnosing and Managing Nontuberculous Mycobacterial Lung Disease

April W. Armstrong, MD, MPH - Staying on Target Against Moderate to Severe Psoriasis: Strategies for Achieving Sustained Benefits Through TYK2 Inhibition

Gil Rabinovici, MD - At the Ready for a New Standard of Alzheimer's Care: Preparing Your Practice for the New Era of Amyloid-Targeting Therapies

Onyema Ogbuagu, MD, FACP, FIDSA - Adjusting HIV Treatment for ART-Experienced People With HIV: Switching ART to Address Antiretroviral Resistance, Adverse Events, and Adherence Barriers

Komal Jhaveri, MD, FACP - Embracing Progress, Transforming Treatment, Empowering Patients: Harnessing the Potential of TROP2-Targeted ADC Therapy in TNBC and HR+, HER2- Breast Cancer

Marc S. Sabatine, MD, MPH - Emerging Options for Targeting PCSK9 in Hypercholesterolemia Management: Visualizing New Routes to Individualized Care

Jacinda (JAM) Abdul-Mutakabbir, PharmD, MPH - Pharmacist-Led RSV Immunization Strategies: Leveraging Trust to Overcome Vaccine Hesitancy

April W. Armstrong, MD, MPH - All Things Considered in Psoriasis Management: Looking at the Role of Biologic Therapies in a Holistic Approach

Bradley J. Monk, MD, FACS, FACOG - Advancing Immunotherapy: Revolutionizing Cervical Cancer Treatment